Navigation Links
Zogenix Initiates Pivotal Phase 3 Clinical Trial for Novel Formulation of Oral Controlled-Release Hydrocodone
Date:3/17/2010

SAN DIEGO, March 17 /PRNewswire/ -- Zogenix, Inc. ("Zogenix"), a privately held pharmaceutical company, announced that it has initiated a pivotal Phase 3 clinical trial with ZX002, a novel, oral, controlled-release formulation of hydrocodone without acetaminophen.  ZX002 is being developed for the treatment of moderate to severe pain in individuals who require around-the-clock opioid therapy for the control of pain.  Hydrocodone is the most widely prescribed drug in the United States, but there are currently no products available with hydrocodone only, or with controlled-release formulations.  ZX002, which incorporates Elan's proprietary SODAS® technology, offers a unique controlled-release profile which utilizes both immediate release and extended release properties designed to enable twice daily dosing.

"We are pleased to be initiating this pivotal Phase 3 trial of ZX002 as the first single-entity, controlled-release hydrocodone formulation," said Cynthia Robinson, Ph.D., chief development officer of Zogenix.  "We believe this hydrocodone therapy could offer significant benefits to both the patient and the practicing physician by allowing for less frequent dosing with a customized controlled-release profile and the ability to titrate to higher hydrocodone doses than currently recommended for hydrocodone products burdened by combination formulations. Further, we believe ZX002 may offer patients an option for the treatment of their chronic pain that potentially avoids some of the serious side effects that can accompany chronic use of combination opioids that contain acetaminophen, or other n
'/>"/>

SOURCE Zogenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
2. ISIS Initiates Phase 1 Clinical Trial of ISIS-SOD1Rx in Patients With ALS
3. Kinex Pharmaceuticals Initiates a Phase 2 Clinical Trial of KX2-391 in Patients with Prostate Cancer
4. QRxPharma Initiates Second Pivotal Phase 3 Study of MoxDuo(TM)IR Dual-Opioid(TM) for NDA Submission
5. Daiichi Sankyo Initiates Largest Single, Double-Blind, Randomized, Phase III Trial for Treatment and Prevention of Recurrent Venous Thromboembolism
6. Celsis Initiates Patent Infringement Action Against XenoTech and Sekisui
7. Romark Initiates Clinical Trial of Alinia for Treatment of Influenza
8. Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination With Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV)
9. ChemoCentryx Initiates Clinical Trial of CCX168, A Novel Small Molecule C5aR Antagonist for the Treatment of Inflammatory and Autoimmune Diseases
10. Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression
11. Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014 Kinex Pharmaceuticals announced ... KX2-361 at Roswell Park Cancer Institute. KX2-361 ... drug that has shown potent inhibitory activity against a ... that are resistant to Temozolomide (T98G), the most widely ... a well-established brain tumor mouse model, KX2-361 consistently clears ...
(Date:12/24/2014)... 2014  The International Trade Commission (ITC) issued its final ... Medical. In a notice issued on December 23, the ITC ... on its humidifier was invalid. BMC President, ... are very excited with the ITC,s decision in this case. ... taken since the very beginning on the key patents in ...
(Date:12/24/2014)...  Diplomat Pharmacy, Inc. (NYSE: DPLO ), ... announce Jennifer Hagerman , Pharm.D., AE-C, senior director ... as the president of the Michigan Pharmacists Association on ... place Feb. 28, 2015, at the MPA Annual Convention ... Center in Detroit, Michigan . Hagerman ...
Breaking Medicine Technology:Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3ITC Final Decision Goes Against ResMed (RMD) Monumental Win for 3B/BMC 2Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 2Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 3
... 2011 Lloydspharmacy, the community pharmacy chain, has revealed that one ... 11 million** adults - has taken or applied medicines which they ... that more than half (53%) of people do not always check ... to a family member. This is worrying considering ...
... Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC) announced ... peer reviewed journal, Leukemia & Lymphoma ... phase I/II clinical trial evaluating the effect of ... patients with aggressive non-Hodgkin,s lymphoma ("NHL") who relapsed ...
Cached Medicine Technology:Lloydspharmacy Reveals Over 11 Million Britons Risking Health by Taking Old Medicines 2Lloydspharmacy Reveals Over 11 Million Britons Risking Health by Taking Old Medicines 3Substitution of Pixantrone for Doxorubicin in CHOP Chemotherapy Regimen Produces High Rates of Complete Remissions and Long-Term Disease Free Survival in Patients with Relapsed/Refractory Aggressive NHL Who Previously Failed Frontline CHOP Therapy 2Substitution of Pixantrone for Doxorubicin in CHOP Chemotherapy Regimen Produces High Rates of Complete Remissions and Long-Term Disease Free Survival in Patients with Relapsed/Refractory Aggressive NHL Who Previously Failed Frontline CHOP Therapy 3Substitution of Pixantrone for Doxorubicin in CHOP Chemotherapy Regimen Produces High Rates of Complete Remissions and Long-Term Disease Free Survival in Patients with Relapsed/Refractory Aggressive NHL Who Previously Failed Frontline CHOP Therapy 4Substitution of Pixantrone for Doxorubicin in CHOP Chemotherapy Regimen Produces High Rates of Complete Remissions and Long-Term Disease Free Survival in Patients with Relapsed/Refractory Aggressive NHL Who Previously Failed Frontline CHOP Therapy 5Substitution of Pixantrone for Doxorubicin in CHOP Chemotherapy Regimen Produces High Rates of Complete Remissions and Long-Term Disease Free Survival in Patients with Relapsed/Refractory Aggressive NHL Who Previously Failed Frontline CHOP Therapy 6
(Date:12/25/2014)... This is a professional and in-depth study on ... a focus on the Chinese market. The report provides ... manufacturers and is a valuable source of guidance and ... This report provides a basic overview of the industry ... part, the report presents the company profile, product specifications, ...
(Date:12/25/2014)... Product liability lawsuits filed in the ... http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in federal court, ... in the U.S. District Court, Northern District of Ohio ... conference on January 7, 2015, at the Paul G. ... Palm Beach, Florida. The Conference is scheduled to begin ...
(Date:12/25/2014)... The short film “Color of Honor” by young ... a true 9/11 hero, Welles Remy Crowther. It has been ... hours of Nuremberg International Short Film Festival and the 8th ... screenwriter and director Luciana Lagana plays the mother of ... husband, Gregory Graham - Graham plays a heroic ...
(Date:12/25/2014)... December 25, 2014 When head lice hits ... in a frenzy to get rid of it while keeping ... in Coral Gables now have the solution right in their ... clinic location, Lice Troopers provides full spectrum head lice screening ... Gable area, including Sunset, Key Biscayne, Brickell, Coconut Grove, Kendall, ...
(Date:12/25/2014)... Overeating is common during the holidays, but there are strategies ... "Don,t arrive at a party hungry. It may seem ... attending a party, but deprivation leads to hunger, and hunger ... Hospital in Mount Kisco, N.Y., said in a hospital news ... and even to have a snack before attending a party ...
Breaking Medicine News(10 mins):Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2
... Smokerman Can,t because he smokes cigarettes... New anti-tobacco ads star a toy ... the health effects from his tobacco use. , ... Salt Lake City, ... Lake City today launched a new series of television ads starring a ...
... 11 The Grand Opening Celebration of Ocean,Blue ... from 7:00 until,10:00 p.m. Ocean Blue Plastic Surgery ... most prestigious addresses. Guests are invited to enjoy ... Plastic Surgery while,sampling hors d,oeuvres and sipping cocktails ...
... The Beryl Institute is seeking speakers,for its annual ... Worth,Metroplex. The theme for the conference is "The ... to improving customer service in,healthcare and will feature ... ways healthcare organizations can deliver,superior customer service., ...
... HealthCore, WellPoint,s health,outcomes research subsidiary, today presented ... in collaboration with the National Lipid Association,that ... American adults. The study,findings, presented during the ... Orleans, suggest that regardless of gains made ...
... General Nutrition Centers, Inc.,("GNC" the "Company" or "we"), ... reported its financial results for the third,quarter ended ... indirect wholly owned subsidiary of GNC Parent LLC,which ... ("Ares") and,Ontario Teachers, Pension Plan Board ("Teachers") through ...
... Before Holidays, WASHINGTON, Nov. 11 The American Red ... cards to service men,and women in the United States and ... the public is invited to send holiday,cards with their message ... Red Cross and Pitney Bowes will then screen cards for ...
Cached Medicine News:Health News:Anti-Tobacco Campaign Targets Twelve-and-Under Youth with Debut of "Smokerman" in New Television Ads 2Health News:Anti-Tobacco Campaign Targets Twelve-and-Under Youth with Debut of "Smokerman" in New Television Ads 3Health News:Ocean Blue Plastic Surgery to Open This Month on Brickell Avenue 2Health News:The Beryl Institute Announces Call for Speakers for 2009 Conference Dedicated to Healthcare Customer Service: 'The Pursuit of Excellence' 2Health News:Triglyceride Levels Continue to Rise in the United States Despite Increased Use of Cholesterol-Lowering Medications 2Health News:Triglyceride Levels Continue to Rise in the United States Despite Increased Use of Cholesterol-Lowering Medications 3Health News:Triglyceride Levels Continue to Rise in the United States Despite Increased Use of Cholesterol-Lowering Medications 4Health News:General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results 2Health News:General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results 3Health News:General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results 4Health News:General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results 5Health News:General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results 6Health News:General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results 7Health News:General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results 8Health News:General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results 9Health News:General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results 10Health News:'Holiday Mail for Heroes' to Deliver One Million Cards to Service Members and Families 2Health News:'Holiday Mail for Heroes' to Deliver One Million Cards to Service Members and Families 3
... most advanced system for laser therapy available today. ... optical fiber handpiece that allows to perform linear ... the 20% of the energy reflected by the ... a special gel which optimizes the optical coupling ...
... with the capability of emission at two different ... and ablative capacities.Smart 1064 DW is able to ... ordinary 1064 nm (with powers selectable among 4 ... among 2 and 25 W). This second wavelength ...
... The SmartPulse 10.6 CO2 system was expressly ... in cosmetic surgery. A special source and ... it possible to create particular high energy ... impulses (technically known as 'top-flat shaped') allow ...
... laser is the ideal instrument for safe, ... Plus, the majority of surface lesions can ... range of scar tissue, with a minimum ... with the elimination of anaesthetics, risks and ...
Medicine Products: